The update comes as analysts raise concerns about the prospect of global olive oil supplies swinging dramatically from one season to the next.
This is the feed from
CNBC - Healthcare
Is this your feed? Claim it!
Publisher: Unclaimed!
Message frequency: 1.03 / day
Message History
Ahead of the CNBC Investing Club's July Monthly Meeting, here's a look at what moved our three top and bottom performers since our last meeting.
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into AI.
Johnson & Johnson's quarter was imperfect, but enough is going right to validate our ownership of the stock.